Chinese biopharmaceutical company Yingli Pharma has obtained US Food and Drug Administration (FDA) approval for a Phase III trial of linperlisib for relapsed/refractory (r/r) peripheral T-cell ...

Chinese solar panel manufacturer Yingli this morning revealed it is talks with its lenders about a potential takeover of its chief Chinese business units. Yingli Green Energy Holding Company ...

With more than $1.6bn in short-term debt and a lack of cash resources, Yingli has warned that it may have to liquidate assets. The leading solar manufacturer issues SEC Filing in which it raises ...

Yingli Solar has unveiled new bifacial n-type TOPCon solar modules for rooftop applications. “Using lighter materials and frames, Panda 3.0 Pro 108 cell has advantages of lightness and easy ...

Yingli received her Bachelor’s Degree in Construction Management from Chongqing University, China in 2016. Afterward, she continued her Master's study at Chongqing University to get her degrees in ...

This is the product's overall performance score, based on key tests conducted by our industry experts in the CHOICE labs.